Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "668f8c184c223a02e4795313",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Armodafinil 50mg",
"description": "ARMOODFINE 50 \nArmodafinil (50mg)\nOverview\nARMOODFINE 50, containing Armodafinil 50mg, is a prescription medication primarily used to promote wakefulness in individuals experiencing excessive sleepiness due to conditions such as narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder (SWSD). Armodafinil is a wakefulness-promoting agent that works by altering neurotransmitters in the brain.\n\nUses\nNarcolepsy: Helps individuals with narcolepsy stay awake during the day.\nObstructive Sleep Apnea (OSA): Reduces excessive daytime sleepiness in individuals with OSA.\nShift Work Sleep Disorder (SWSD): Assists those who work non-traditional hours stay awake and alert during their shifts.\nDosage\nStandard Dose: The typical dosage for ARMOODFINE 50 is 50mg taken once daily, usually in the morning for OSA and narcolepsy, or one hour before the start of the work shift for SWSD.\nAdministration: Should be taken orally with or without food.\nSide Effects\nCommon Side Effects: Headache, nausea, dizziness, and insomnia.\nSevere Side Effects: Rash, allergic reactions, anxiety, and depression. Immediate medical attention should be sought if severe side effects occur.\nPrice\nThe price of ARMOODFINE 50 can vary depending on the pharmacy, location, and whether you have insurance coverage. It's advisable to check with local pharmacies or online retailers for specific pricing information.\nConclusion\nARMOODFINE 50 is a valuable medication for individuals struggling with excessive daytime sleepiness due to narcolepsy, OSA, or SWSD. While it can significantly improve wakefulness and productivity, it's important to use it under the supervision of a healthcare provider due to potential side effects and interactions with other medications. Always follow the prescribed dosage and consult your doctor if you experience any adverse reactions or have concerns about taking ARMOODFINE 50.\nFor further information\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBUY NOW\n",
"price": 280.0,
"discountamount": 84.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"work shift",
"typical dosage",
"Armodafinil 50mg",
"online retailers",
"local pharmacies",
"adverse reactions",
"other medications",
"traditional hours",
"prescribed dosage",
"insurance coverage",
"allergic reactions",
"healthcare provider",
"valuable medication",
"Severe Side Effects",
"Common Side Effects",
"excessive sleepiness",
"Dosage Standard Dose",
"potential side effects",
"prescription medication",
"obstructive sleep apnea",
"Shift Work Sleep Disorder",
"wakefulness-promoting agent",
"Immediate medical attention",
"specific pricing information",
"excessive daytime sleepiness"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1941,
"imageuri": "https://productimages.withfloats.com/actual/668f8c233f494c30b941ec10.jpeg",
"tileimageuri": "https://productimages.withfloats.com/tile/668f8c233f494c30b941ec10.jpeg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-07-11T07:39:04.263Z",
"updatedon": "2026-03-12T08:50:18.496Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/armodafinil-50mg/1941",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ARMOODFINE 150",
"category": "NEUROLOGY RANGE",
"tags": [
"Armodafinil side effects",
"Armodafinil 50 mg brand name",
"",
"Armodafinil 50 mg price",
"Armodafinil 50 mg Uses in Hindi",
"Armodafinil dosage",
"Armodafinil side effects teeth",
"Armodafinil uses"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "666ab72d396cee0250f91a0f",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "modafinil 100mg",
"description": "MOODFINE 100 \nModafinil (100mg)\nIntroduction:\nMOODFINE 100mg, containing the active ingredient Modafinil, is a prescription medication used primarily to treat sleep disorders such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder. Modafinil belongs to a class of drugs called eugeroics, which promote wakefulness and alertness. MOODFINE 100mg is designed to help people maintain focus, improve cognitive performance, and manage the symptoms of excessive sleepiness due to these disorders.\n\nUnlike traditional stimulants, Modafinil has a unique mechanism of action that promotes wakefulness without the jittery side effects commonly associated with other wakefulness-promoting drugs or caffeine. While it is not a cure for sleep disorders, it is highly effective at managing symptoms and improving the quality of life for those suffering from excessive daytime sleepiness.\n\nEach tablet of MOODFINE 100mg contains 100mg of Modafinil, and it is typically taken once a day, either in the morning or as prescribed by a healthcare provider. It may also be prescribed off-label for conditions such as ADHD or to improve cognitive function in healthy individuals, although its use in such scenarios is not FDA-approved.\n\nUses of MOODFINE 100mg\n\nNarcolepsy\nNarcolepsy is a chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep. These episodes can occur without warning, making it difficult for individuals to maintain regular daily activities. MOODFINE 100mg helps alleviate excessive daytime sleepiness associated with narcolepsy, allowing individuals to stay awake and engaged in their activities during the day. By increasing wakefulness, it helps reduce the occurrence of sudden sleep attacks, improving overall functioning.\n\nObstructive Sleep Apnea (OSA)\nObstructive Sleep Apnea is a sleep disorder where the airway becomes blocked during sleep, leading to periods of breathing cessation and fragmented sleep. While CPAP therapy (Continuous Positive Airway Pressure) is the standard treatment for OSA, MOODFINE 100mg can be prescribed as an adjunct therapy for excessive daytime sleepiness in individuals who are already using CPAP but still experience fatigue. It helps maintain alertness during the day and improve the quality of life for individuals struggling with daytime sleepiness due to OSA.\n\nShift Work Sleep Disorder (SWSD)\nPeople who work non-traditional hours or rotating shifts often struggle with maintaining regular sleep patterns, leading to daytime drowsiness, fatigue, and poor performance. MOODFINE 100mg is an effective treatment for those suffering from Shift Work Sleep Disorder, as it promotes wakefulness and helps individuals stay alert during their work hours, even when the body’s natural circadian rhythms are out of sync.\n\nOff-label Uses (Cognitive Enhancement)\nIn some cases, MOODFINE 100mg is prescribed off-label to enhance cognitive function in individuals without sleep disorders. It is sometimes used by healthy individuals, particularly in demanding professions or academic settings, to boost focus, concentration, and mental clarity. While not approved by regulatory agencies for cognitive enhancement, studies have suggested that Modafinil may improve executive function, working memory, and overall cognitive performance in certain individuals. It’s important to note that the long-term effects of using Modafinil for cognitive enhancement are still not fully understood.\n\nKey Benefits of MOODFINE 100mg\n\nPromotes Wakefulness and Reduces Sleepiness\nThe primary benefit of MOODFINE 100mg is its ability to reduce excessive daytime sleepiness, particularly in conditions like narcolepsy, OSA, and Shift Work Sleep Disorder. It helps individuals remain awake and alert during the day, allowing them to engage in activities and responsibilities without the constant burden of drowsiness. The unique formulation of Modafinil ensures that this wakefulness is achieved without the common side effects of traditional stimulants like caffeine or amphetamines.\n\nImproves Focus and Cognitive Performance\nIn addition to helping with wakefulness, MOODFINE 100mg has shown potential benefits in enhancing cognitive function. Users often report improvements in concentration, attention, and the ability to focus on tasks for extended periods. For individuals with demanding jobs or academic responsibilities, this boost in cognitive performance can be highly valuable.\n\nMinimal Risk of Dependency\nUnlike traditional stimulants used for similar purposes, MOODFINE 100mg carries a relatively low risk of dependence or addiction. This makes it a preferred choice for individuals who need a consistent way to manage daytime drowsiness without the long-term risks associated with other wakefulness-promoting medications. However, it is still classified as a controlled substance, and its use should be monitored by a healthcare provider.\n\nLong-Lasting Effects\nThe effects of MOODFINE 100mg typically last for a significant portion of the day, making it ideal for individuals with long work hours or those who struggle with daytime sleepiness for extended periods. This sustained wakefulness can enhance productivity, safety, and overall quality of life.\n\nMinimal Side Effects\nCompared to traditional stimulants, MOODFINE 100mg generally has fewer and less severe side effects. Many people tolerate the medication well without experiencing the jitteriness, increased heart rate, or crash that is common with other stimulants.\n\nSide Effects of MOODFINE 100mg\n\nAs with any medication, MOODFINE 100mg can cause side effects, although not everyone will experience them. Most side effects are mild and tend to diminish as the body adjusts to the medication. Some common and less common side effects include:\n\nCommon Side Effects:\n\nHeadache: One of the most frequently reported side effects, which may occur during the first few days of treatment.\n\nNausea: Some individuals may feel queasy, especially when first starting the medication or if taken on an empty stomach.\n\nDizziness: Mild dizziness can occur, especially when standing up quickly.\n\nInsomnia: Since MOODFINE 100mg promotes wakefulness, it can sometimes lead to difficulty sleeping if taken too late in the day.\n\nLess Common Side Effects:\n\nAnxiety and Nervousness: Some users report feelings of restlessness, nervousness, or anxiety.\n\nChest Pain: Although rare, some individuals may experience mild chest discomfort.\n\nElevated Blood Pressure and Heart Rate: In some cases, Modafinil can cause slight increases in heart rate and blood pressure, which should be monitored in individuals with pre-existing heart conditions.\n\nRash: Although uncommon, a rash or skin irritation may occur. If a rash is accompanied by fever or swelling, immediate medical attention should be sought, as this could be a sign of a serious allergic reaction.\n\nMood Changes: Some users may experience mood swings, irritability, or feelings of euphoria.\n\nSerious Side Effects (Rare):\n\nSevere Allergic Reactions: Although extremely rare, some individuals may experience a serious allergic reaction, such as swelling of the throat or difficulty breathing. If any signs of a severe allergic reaction occur, emergency medical help should be sought immediately.\n\nPrecautions and Warnings\n\nPregnancy and Breastfeeding: MOODFINE 100mg should only be used during pregnancy if absolutely necessary, as its effects on the fetus are not well understood. It is also excreted in breast milk, so caution is advised when breastfeeding.\n\nPre-existing Heart Conditions: Individuals with heart problems, including high blood pressure or arrhythmias, should use MOODFINE 100mg with caution and under the supervision of a healthcare provider.\n\nDrug Interactions: MOODFINE 100mg can interact with other medications, including birth control pills, antidepressants, and anticonvulsants. Always inform your healthcare provider about any other medications you are taking.\n\nConclusion\nMOODFINE 100mg (Modafinil) is an effective and well-tolerated medication for managing excessive daytime sleepiness due to conditions such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder. Its ability to promote wakefulness without the jittery side effects common to other stimulants makes it a popular choice for those seeking to improve their daily functioning.",
"price": 129.0,
"discountamount": 38.7,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"mg",
"food",
"EMAIL",
"water",
"abuse",
"memory",
"tablet",
"option",
"patient",
"ability",
"morning",
"Benefits",
"MOODFINE",
"schedule",
"response",
"treatment",
"attention",
"Modafinil",
"Modafinol",
"dependency",
"work shift",
"likelihood",
"narcolepsy",
"individuals",
"bloodstream",
"information",
"Introduction",
"sterispharma",
"sterisonline",
"Key Features",
"CALL/WHATSAPP",
"crucial tasks",
"long-term use",
"Initial Dosage",
"Administration",
"lower potential",
"Reduced Fatigue",
"mental performance",
"Improved Alertness",
"overall wakefulness",
"executive functions",
"cognitive functions",
"healthcare provider",
"higher energy levels",
"excessive sleepiness",
"typical starting dose",
"cognitive performance",
"Wakefulness Promotion",
"Cognitive Enhancement",
"traditional stimulants",
"central nervous system",
"various sleep disorders",
"obstructive sleep apnea",
"Non-Amphetamine Stimulant",
"Shift Work Sleep Disorder",
"wakefulness-promoting agent",
"excessive daytime sleepiness",
"consistent medication levels"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1856,
"imageuri": "https://productimages.withfloats.com/actual/666ab7332d43284d7272c643.jpg",
"tileimageuri": "https://productimages.withfloats.com/tile/666ab7332d43284d7272c643.jpg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-13T09:09:01.625Z",
"updatedon": "2026-03-12T12:08:52.061Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//modafinil-100mg/1856",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MOODFINE 100 ",
"category": "NEUROLOGYRANGE",
"tags": [
"modafinil 100mg uses",
"MOODFINE 100",
"modafinil side effects",
"modafinil side effects long-term",
"modafinil price",
"Modafinol for daytime sleepiness relief",
"Modafinol vs caffeine for focus",
"Modafinol for shift workers sleep disorder",
"Modafinol 100mg vs 200mg dosage",
"Modafinol drug interactions with antidepressants",
"Buy Modafinol online",
"Modafinol price per pill",
"Modafinol buy with prescription",
"Modafinol 100mg buy with promo code"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a5de55aa467a7e64774de83",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Teneligliptin 20mg,Pioglitazone 15mg & Metformin Hydrochloride (Sustained Release) 1000mg Tablets",
"description": "TENELIGOLD PM 1000 brings together three antidiabetic agents — Teneligliptin 20 mg, Pioglitazone 15 mg, and Metformin Hydrochloride (Sustained Release) 1000 mg — in a single tablet built to support glycemic control in adults living with Type 2 Diabetes Mellitus (T2DM). Rather than relying on one pathway, this triple-action formula addresses blood glucose from several angles at once, offering a more rounded approach to sugar management.\n\nProduced under strict pharmaceutical quality benchmarks, TENELIGOLD PM 1000 works to sharpen the body's response to insulin, prompt insulin release in step with rising glucose, and rein in the liver's excess sugar output. It's typically brought into a treatment plan once lifestyle changes and single-drug therapy no longer keep blood sugar within target range.\n\nComposition\n\nEach sustained-release tablet delivers:\n\nTeneligliptin – 20 mg\nPioglitazone – 15 mg\nMetformin Hydrochloride (Sustained Release) – 1000 mg\n\nDosage Form: Sustained Release Tablets\n\nHow TENELIGOLD PM 1000 Works\n\nThis tablet pairs three well-known antidiabetic molecules so their effects complement one another.\n\n1. Teneligliptin 20 mg\n\nA DPP-4 inhibitor, Teneligliptin raises the body's incretin hormone activity, which in turn:\n\nTriggers insulin output only when glucose levels are elevated\nCurbs glucagon release\nFlattens the post-meal blood sugar rise\nKeeps hypoglycemia risk low\n\n2. Pioglitazone 15 mg\n\nBelonging to the Thiazolidinedione (TZD) family, Pioglitazone:\n\nSharpens the body's sensitivity to insulin\nHelps muscle tissue take up and use glucose more effectively\nCuts down insulin resistance\nAids sustained glycemic management over time\n\n3. Metformin SR 1000 mg\n\nA Biguanide-class agent, Metformin SR:\n\nSlows the liver's glucose output\nLimits how much glucose the intestines absorb\nBoosts insulin responsiveness\nDelivers steady blood sugar control across the day\n\nBecause it's released gradually, the sustained-release format is also gentler on the stomach than immediate-release versions.\n\nBenefits of TENELIGOLD PM 1000\n\nWell-Rounded Blood Sugar Control The three-pronged formula works to steady both fasting glucose and the spikes that follow meals.\n\nStronger HbA1c Improvement Used appropriately, this combination therapy may lower HbA1c more than a single-agent approach would.\n\nSharper Insulin Response Pioglitazone's role in easing insulin resistance means the insulin the body produces (or receives) does more work.\n\nSteady, All-Day Coverage Metformin SR's gradual release keeps blood sugar levels more consistent throughout the day.\n\nOne Tablet, Three Medicines Combining proven antidiabetic drugs into a single pill can make treatment simpler and support better adherence.\n\nA Foundation for Long-Term Care Sustained glycemic control, paired with healthy lifestyle habits, may help lower the risk of diabetes-related complications down the line.\n\nIndications\n\nTENELIGOLD PM 1000 is intended as an add-on to diet and exercise for improving blood sugar control in adults with Type 2 Diabetes Mellitus, particularly where a physician determines combination therapy is the right course.\n\nIt is not meant for Type 1 Diabetes Mellitus or diabetic ketoacidosis.\n\nKey Features\nTriple-combination antidiabetic tablet\nSustained-release Metformin component\nSupports both fasting and post-meal glucose control\nImproves insulin sensitivity\nEncourages glucose-responsive insulin release\nLowers hepatic glucose output\nOnce-daily dosing convenience, as prescribed\nManufactured to rigorous quality standards\nSuited to long-term diabetes management under medical guidance\nWho May Benefit?\n\nPhysicians may consider TENELIGOLD PM 1000 for adult T2DM patients who:\n\nContinue to have unmanaged blood sugar despite two-drug therapy\nNeed better HbA1c outcomes\nShow marked insulin resistance\nRequire broader glycemic coverage\nWould benefit from a sustained-release metformin option\n\nEvery treatment decision should be tailored by the prescribing doctor.\n\nDirections for Use\nTake exactly as directed by your physician.\nSwallow the tablet whole with water.\nNever crush, chew, or split the sustained-release tablet.\nTaking it with food is generally advised to ease stomach upset.\nPair the medicine with your prescribed diet and exercise plan for best results.\nPossible Side Effects\n\nAs with any medicine, TENELIGOLD PM 1000 can cause side effects, though not everyone will experience them.\n\nCommonly reported:\n\nNausea\nDiarrhea\nStomach discomfort\nHeadache\nSlight weight gain\nSwelling in the extremities (peripheral edema), linked mainly to pioglitazone\n\nLess common but serious:\n\nLactic acidosis (a metformin-related risk, more likely in vulnerable patients)\nWorsening heart failure (associated with pioglitazone in select patients)\nAllergic reactions\nAbnormal liver function\n\nSeek urgent medical care if severe weakness, breathing difficulty, chest pain, or ongoing abdominal pain develops.\n\nPrecautions\n\nTell your healthcare provider before starting TENELIGOLD PM 1000 if you have any of the following:\n\nKidney disease\nLiver disease\nHeart failure\nBladder cancer, present or past\nPancreatitis\nVitamin B12 deficiency\nSevere dehydration\nAn upcoming surgery or imaging test involving iodinated contrast dye\n\nRoutine checks of blood glucose, HbA1c, kidney function, liver function, and related markers are advised throughout treatment.\n\nStorage Instructions\nStore below 30°C.\nKeep away from moisture and direct sunlight.\nLeave in the original packaging.\nStore out of children's reach.\nWhy Choose TENELIGOLD PM 1000?\n\nTENELIGOLD PM 1000 brings three established antidiabetic medicines together in one sustained-release tablet, giving physicians a way to simplify a patient's regimen while still addressing multiple facets of Type 2 Diabetes. Through its complementary mechanisms, it offers a well-rounded route to blood sugar control for suitably selected adult patients under medical supervision.\n\nFrequently Asked Questions (FAQs)\n\nWhat is TENELIGOLD PM 1000 used for? It's prescribed to help manage Type 2 Diabetes Mellitus in adults whose blood sugar needs combination therapy alongside diet and exercise.\n\nIs TENELIGOLD PM 1000 meant to be taken every day? Yes, exactly as your physician prescribes. Don't adjust the dose on your own.\n\nCan TENELIGOLD PM 1000 lead to low blood sugar? Taken alone, the hypoglycemia risk is generally low, though it can rise if combined with insulin or sulfonylureas.\n\nCan I stop the medicine once my sugar levels normalize? No — diabetes is a long-term condition. Keep taking the medicine unless your doctor says otherwise.\n\nIs this medicine right for Type 1 Diabetes? No. It's formulated only for adults with Type 2 Diabetes Mellitus.\n\nShould TENELIGOLD PM 1000 be taken with food? Yes, taking it with meals is generally recommended to reduce stomach-related side effects.\n\nDoes it help bring down HbA1c? Yes — used as directed alongside lifestyle changes, it can support meaningful HbA1c improvement.\n\nPrescription only – consult your doctor.\n\n",
"price": 385.0,
"discountamount": 95.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2473,
"imageuri": "https://productimages.withfloats.com/actual/6a5de55cdc76c6268e3fe287.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a5de55cdc76c6268e3fe287.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-20T09:07:38.732Z",
"updatedon": "2026-07-20T09:07:38.732Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//teneligliptin-20mg-pioglitazone-15mg-metformin-hydrochloride-sustained-release-1000mg-tablets/2473",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TENELIGOLD PM 1000",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a460bf90c11f3c74a816c87",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "methylprednisolone sodium succinate for injection usp",
"description": "Methylprednisolone Sodium Succinate for Injection USP is a fast-acting corticosteroid administered intravenously or intramuscularly to control severe inflammation, allergic reactions, and autoimmune flare-ups. It works by rapidly suppressing the immune and inflammatory response and is used in hospital or clinical settings for acute conditions such as severe asthma attacks, anaphylaxis, autoimmune disease flares, and spinal cord injury protocols. It is a Schedule H prescription drug administered only under medical supervision.\n\nWhat Is Methylprednisolone Sodium Succinate for Injection USP?\n\nMethylprednisolone Sodium Succinate for Injection USP is a water-soluble, injectable corticosteroid used for rapid control of severe inflammatory, allergic, and autoimmune conditions. It is manufactured to United States Pharmacopeia (USP) standards and is typically administered by a healthcare professional via intravenous (IV) or intramuscular (IM) route when fast, high-potency anti-inflammatory or immunosuppressive action is required — situations where oral steroids act too slowly or oral intake isn't feasible.\n\nHow It Works\n\nMethylprednisolone sodium succinate is a synthetic glucocorticoid that acts rapidly once reconstituted and injected.\n\n\nBinds glucocorticoid receptors – enters cells and binds intracellular receptors that regulate inflammatory gene expression.\nSuppresses inflammatory mediators – reduces production of prostaglandins, leukotrienes, and cytokines responsible for swelling, redness, and pain.\nStabilizes cell membranes – reduces capillary permeability, limiting fluid leakage and tissue swelling at the site of inflammation.\nDampens immune overactivity – suppresses lymphocyte and macrophage activity, calming autoimmune or allergic overreactions.\nDelivers rapid systemic action – because it's water-soluble and given IV/IM, onset of anti-inflammatory effect is significantly faster than oral steroids.\n\n\nClinical Indications\n\nConditionWhy Methylprednisolone Injection Is UsedSevere Allergic Reactions / AnaphylaxisRapidly controls swelling, airway inflammation, and allergic cascadeAcute Asthma Exacerbation / COPD FlareReduces airway inflammation when inhalers alone are insufficientAutoimmune Disease Flares (Lupus, Rheumatoid Arthritis)High-dose pulse therapy to control acute flaresSpinal Cord Injury (acute, under specialist protocol)Used in specific clinical protocols to limit secondary inflammationSevere Dermatologic ReactionsControls widespread inflammatory skin reactionsPost-Transplant / Organ Rejection ManagementUsed as part of immunosuppressive regimens\n\nDosage & Administration\n\nParameterRecommendationTypical Adult Dose10–40 mg IV, may range up to 30 mg/kg in high-dose pulse therapy for specific conditionsRouteIntravenous (IV) injection/infusion or Intramuscular (IM) injectionFrequencyAs directed by the treating physician; often single dose or short tapering courseReconstitutionMust be reconstituted only with the accompanying diluent as per product insert, immediately before useAdministration SettingHospital, clinic, or under direct medical/nursing supervision onlyDurationShort-term acute use unless otherwise directed; long-term use requires specialist monitoring\n\nThis is a Schedule H prescription-only medicine. Dosage must be determined and administered by a qualified healthcare professional.\n\nPrecautions\n\n\nTo be administered only by or under the supervision of a healthcare professional.\nNot for self-administration or home use.\nInform the doctor of any active infections, as corticosteroids can mask symptoms and suppress immune response.\nUse with caution in patients with diabetes, hypertension, peptic ulcer disease, osteoporosis, or psychiatric history.\nAvoid live vaccines during treatment due to immunosuppressive effects.\nPregnant or breastfeeding patients should use only under strict medical guidance.\nAbrupt discontinuation after prolonged use should be avoided; tapering may be required as advised by the physician.\n\n\nPossible Side Effects\n\nMost side effects relate to the drug's systemic corticosteroid action and are monitored by the administering clinician:\n\n\nElevated blood sugar levels\nFluid retention, increased blood pressure\nMood changes, insomnia, or restlessness\nNausea or gastrointestinal discomfort\nIncreased susceptibility to infection\nInjection site reactions\n\n\nSerious side effects requiring immediate medical attention include severe allergic reaction, signs of infection (fever, chills), significant mood or behavioral changes, unusual swelling, or vision disturbances. Because this is administered in a clinical setting, the healthcare team monitors for these actively.\n\nComparison: Methylprednisolone vs. Other Injectable Corticosteroids\n\nDrugRelative PotencyCommon Use CaseRouteMethylprednisolone Sodium SuccinateHighAcute severe inflammation, autoimmune flaresIV/IMHydrocortisone Sodium SuccinateLowerAdrenal insufficiency, milder acute inflammationIV/IMDexamethasone Sodium PhosphateVery HighCerebral edema, severe allergic/inflammatory conditionsIV/IMBetamethasone Sodium PhosphateHighAllergic and inflammatory conditions, fetal lung maturityIV/IMTriamcinolone AcetonideModerate (depot)Localized/intra-articular inflammationIM/Intra-articular\n\nKey Statistics\n\nStatisticData PointSourceOnset of anti-inflammatory action after IV administrationWithin 1–2 hours for measurable effectClinical pharmacology references, USP monographUse in acute severe asthma protocolsRecommended as part of systemic corticosteroid therapy in emergency guidelinesGlobal Initiative for Asthma (GINA) guidelinesHospital use in anaphylaxis managementIncluded as an adjunct in anaphylaxis treatment protocols alongside epinephrineWorld Allergy Organization guidanceHigh-dose pulse therapy applicationUsed in select autoimmune flare protocols under specialist supervisionPublished rheumatology treatment guidelines\n\nExpert Insight\n\n[Insert verified physician or clinical pharmacologist commentary here — Claude has not fabricated a quote. Recommend sourcing a short, attributable statement from a Steris Healthcare medical advisor or a cited clinical guideline before publishing.]\n\nConclusion\n\nMethylprednisolone Sodium Succinate for Injection USP is a high-potency, fast-acting corticosteroid reserved for situations where rapid control of severe inflammation, allergic reaction, or autoimmune flare is essential. Administered only under clinical supervision, it plays a critical role in emergency and hospital-based treatment protocols — from anaphylaxis and acute asthma to autoimmune disease management. As a Schedule H medicine, it must never be self-administered; dosage, route, and duration should always be determined by a qualified physician based on the patient's condition. For pharmacopoeia-grade quality and reliable hospital supply, source this injection through a WHO-GMP certified manufacturer.\n\nPrescription only – consult your doctor.\n\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n\n1. What is methylprednisolone sodium succinate injection used for?\nIt is used to rapidly control severe inflammation, allergic reactions, and autoimmune flare-ups, such as anaphylaxis, acute asthma attacks, and lupus or rheumatoid arthritis flares. It is administered under medical supervision in hospital or clinical settings.\n\n2. Is methylprednisolone injection a steroid?\nYes, it is a synthetic corticosteroid (glucocorticoid) that works by suppressing inflammatory and immune responses in the body, providing rapid relief in acute, severe conditions.\n\n3. How is methylprednisolone sodium succinate injection given?\nIt is given by a healthcare professional via intravenous (IV) or intramuscular (IM) injection, after being reconstituted with the correct diluent immediately before administration. It is not for self-injection or home use.\n\n4. How fast does methylprednisolone injection start working?\nBecause it is water-soluble and given directly into the bloodstream or muscle, measurable anti-inflammatory effects typically begin within one to two hours of administration.\n\n5. What are the side effects of methylprednisolone injection?\nCommon effects include elevated blood sugar, fluid retention, mood changes, and increased infection risk. These are monitored by the administering healthcare team, and serious reactions are managed promptly in a clinical setting.\n\n6. Is methylprednisolone sodium succinate injection available without a prescription?\nNo. It is a Schedule H prescription-only medicine that must be administered by or under the direct supervision of a qualified healthcare professional.\n\n7. What is the difference between methylprednisolone and dexamethasone injection?\nBoth are injectable corticosteroids, but dexamethasone has a longer duration of action and higher relative potency, while methylprednisolone is often preferred for acute pulse therapy and shorter-acting systemic control. The choice depends on the clinical scenario and physician judgment.\n\n8. Can methylprednisolone injection be used in pregnancy?\nIt may be used in pregnancy only when clearly necessary and under strict medical supervision, as the treating physician will weigh the benefits against potential risks for the specific condition being treated.",
"price": 47.0,
"discountamount": 19.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2465,
"imageuri": "https://productimages.withfloats.com/actual/6a460bfb9f5529389b8b15b8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a460bfb9f5529389b8b15b8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-02T06:58:01.631Z",
"updatedon": "2026-07-02T06:58:01.631Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//methylprednisolone-sodium-succinate-for-injection-usp/2465",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "METHIDENOSOLE 40 INJ",
"category": "GENERAL RANGE",
"tags": [
"methylprednisolone sodium succinate injection uses",
"methylprednisolone sodium succinate injection uses in hindi",
"methylprednisolone sodium succinate",
"methylprednisolone sodium succinate injection",
"inj methylprednisolone sodium succinate",
"methylprednisolone sodium succinate uses in hindi",
"methylprednisolone sodium succinate for injection",
"methylprednisolone sodium succinate injection usp"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a43bee2d208c802be053f9d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg",
"description": "Managing type 2 diabetes often requires more than a single medication to achieve long-term blood sugar control. Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a triple-combination prescription medicine formulated to help adults with type 2 diabetes maintain healthy glucose levels when diet, exercise, and single-drug therapy are not enough.\n\nThis advanced combination works through three different mechanisms to improve insulin sensitivity, reduce glucose production by the liver, and enhance the body's natural insulin response after meals. Because of its multi-action approach, it is frequently prescribed by healthcare professionals for patients requiring comprehensive glycemic control.\n\nIf you are searching for Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg, this guide covers everything you need to know—including how it works, benefits, dosage information, side effects, precautions, storage, and frequently asked questions.\n\nWhat is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a prescription oral anti-diabetic medicine used to manage Type 2 Diabetes Mellitus. It combines three clinically proven medicines into one convenient tablet to provide better blood sugar management throughout the day.\n\nThe formulation contains:\n\nSitagliptin 100 mg – A DPP-4 inhibitor that increases incretin hormones to improve insulin secretion.\nMetformin Hydrochloride 1000 mg Sustained Release – A biguanide that lowers glucose production by the liver and improves insulin sensitivity.\nPioglitazone 15 mg – A thiazolidinedione that enhances the body's response to insulin.\n\nTogether, these ingredients target multiple causes of high blood sugar, helping patients achieve better diabetes control while reducing the need for multiple separate medications.\n\nHow Does Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg Work?\n\nThis triple-combination tablet works through complementary mechanisms:\n\n1. Sitagliptin\n\nSitagliptin inhibits the DPP-4 enzyme, allowing incretin hormones to remain active longer. These hormones increase insulin release after meals and reduce excess glucagon production.\n\n2. Metformin SR\n\nMetformin Sustained Release decreases glucose production in the liver, reduces intestinal glucose absorption, and improves insulin sensitivity without causing excessive insulin release.\n\n3. Pioglitazone\n\nPioglitazone improves insulin sensitivity in muscle and fat tissues, enabling cells to utilize glucose more effectively.\n\nThe combination helps maintain consistent blood sugar levels throughout the day while lowering both fasting and post-meal glucose.\n\nWhy is This Triple Combination Important?\n\nType 2 diabetes progresses over time, making it difficult for many patients to control blood sugar using a single medication. A triple therapy offers several advantages:\n\nBetter HbA1c reduction\nMultiple mechanisms of action\nReduced insulin resistance\nImproved post-meal glucose control\nLower fasting blood sugar\nSimplified treatment with one tablet\nImproved medication adherence\nReduced need for additional medications\n\nHealthcare providers often prescribe this combination when dual therapy no longer provides adequate glucose control.\n\nKey Benefits of Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\nExcellent Blood Sugar Control\n\nThe medicine helps reduce both fasting and postprandial blood glucose levels effectively.\n\nTriple Mechanism of Action\n\nEach ingredient targets a different pathway involved in diabetes, resulting in more comprehensive glycemic control.\n\nImproved Insulin Sensitivity\n\nPioglitazone increases insulin responsiveness, helping the body utilize glucose more efficiently.\n\nReduced Liver Glucose Production\n\nMetformin decreases glucose release from the liver, preventing unnecessary increases in blood sugar.\n\nSupports Long-Term Diabetes Management\n\nRegular use, alongside lifestyle modifications, contributes to improved HbA1c levels and reduced diabetes-related complications.\n\nConvenient Once-Daily Regimen\n\nCombining three medicines into a single tablet improves treatment convenience and supports better compliance.\n\nWho May Benefit from This Medicine?\n\nHealthcare professionals may prescribe this medication for adults with Type 2 Diabetes who:\n\nHave uncontrolled blood sugar despite dual therapy\nRequire triple oral anti-diabetic therapy\nHave elevated HbA1c levels\nNeed improved insulin sensitivity\nPrefer fewer tablets in their treatment plan\nAre following dietary and exercise recommendations but require additional glucose control\n\nThis medicine is not intended for Type 1 Diabetes or diabetic ketoacidosis.\n\nHow to Take Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\n\nAlways follow your physician's instructions.\n\nGeneral recommendations include:\n\nTake once daily or as prescribed.\nSwallow the tablet whole.\nDo not crush, split, or chew the sustained-release tablet.\nTake with food to reduce stomach discomfort.\nTake it at the same time each day.\nContinue exercising and following a diabetic meal plan.\n\nNever stop treatment without consulting your healthcare provider.\n\nPossible Side Effects\n\nLike all prescription medicines, this combination may cause side effects, although not everyone experiences them.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nDiarrhea\nHeadache\nUpper respiratory infection\nWeight gain\nSwelling of feet or ankles\nMuscle aches\nDizziness\n\nSeek immediate medical attention if you experience:\n\nSevere allergic reaction\nPersistent vomiting\nDifficulty breathing\nSevere abdominal pain\nUnusual fatigue\nYellowing of skin or eyes\nSymptoms of lactic acidosis\nSigns of heart failure, such as rapid weight gain or shortness of breath\nPrecautions Before Using This Medicine\n\nInform your healthcare provider if you have:\n\nKidney disease\nLiver disease\nHeart failure\nBladder cancer history\nPancreatitis\nSevere dehydration\nAlcohol dependence\nVitamin B12 deficiency\nPlanned surgery or imaging with contrast dye\n\nWomen who are pregnant or breastfeeding should use this medicine only under medical supervision.\n\nDrug Interactions\n\nTell your doctor about all medicines you take, including:\n\nInsulin\nSulfonylureas\nDiuretics\nCorticosteroids\nThyroid medicines\nBlood pressure medicines\nRifampicin\nAlcohol\nCimetidine\nCertain antifungal medicines\n\nProper medication review helps minimize interaction risks.\n\nLifestyle Tips for Better Diabetes Control\n\nMedicine works best when combined with healthy lifestyle habits.\n\nRecommended practices include:\n\nFollow a balanced diabetic diet.\nExercise for at least 30 minutes most days.\nMonitor blood sugar regularly.\nMaintain a healthy body weight.\nStay hydrated.\nAvoid smoking.\nLimit alcohol intake.\nGet regular HbA1c tests.\nManage stress effectively.\nAttend routine medical check-ups.\nStorage Instructions\n\nStore the tablets:\n\nBelow 25°C\nIn a cool, dry place\nAway from moisture and direct sunlight\nIn the original packaging\nOut of reach of children and pets\n\nDo not use expired medicine.\n\nWhy Healthcare Professionals Choose This Triple Combination\n\nDoctors frequently recommend Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg because it addresses multiple aspects of diabetes management in a single formulation. By improving insulin secretion, reducing hepatic glucose production, and enhancing insulin sensitivity, it provides comprehensive glycemic control while simplifying treatment. When combined with a healthy lifestyle and regular medical follow-up, it can support long-term diabetes management and help reduce the risk of complications associated with uncontrolled blood sugar.\n\nConclusion\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is an effective prescription medication designed for adults with Type 2 Diabetes Mellitus who require stronger blood sugar management than single or dual therapy can provide. Its triple-action formula offers improved glycemic control, better insulin utilization, and convenient once-daily dosing. While highly effective, it should always be used under the guidance of a qualified healthcare professional, together with a balanced diet, regular physical activity, and routine blood sugar monitoring for the best long-term outcomes.\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n1. What is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg used for?\n\nIt is prescribed to help adults with Type 2 Diabetes Mellitus control blood sugar when lifestyle changes and other oral medicines do not provide adequate glycemic control.\n\n2. How does this triple-combination tablet work?\n\nIt combines three medicines that increase insulin release after meals, reduce glucose production by the liver, and improve the body's sensitivity to insulin, resulting in better overall blood sugar control.\n\n3. Can this medicine be taken once daily?\n\nYes. Many patients take it once daily, but the exact dosage and timing should always follow the prescribing doctor's instructions.\n\n4. Should I take this tablet with food?\n\nYes. Taking it with meals helps reduce stomach-related side effects associated with metformin and improves tolerability.\n\n5. Can this medicine cure diabetes?\n\nNo. It helps control blood sugar levels but does not cure Type 2 Diabetes. Long-term treatment, healthy eating, exercise, and regular monitoring remain essential.\n\n6. What should I do if I miss a dose?\n\nTake the missed dose as soon as you remember unless it is nearly time for your next scheduled dose. Do not take two doses together to make up for a missed dose.\n\n7. Can this medicine cause low blood sugar?\n\nOn its own, the risk is relatively low. However, the likelihood increases when it is used with insulin or sulfonylurea medicines, or if meals are skipped.\n\n8. Is this medicine safe for patients with kidney disease?\n\nPatients with kidney impairment require medical evaluation before using this medicine, particularly because metformin may not be suitable in severe kidney dysfunction.\n\n9. Can I drink alcohol while taking this medication?\n\nAlcohol intake should be limited or avoided, as excessive consumption may increase the risk of serious side effects, including lactic acidosis.\n\n10. Who should not use Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nIt should not be used without medical advice by individuals with Type 1 Diabetes, diabetic ketoacidosis, severe kidney disease, certain liver conditions, or a history of serious hypersensitivity to any of its ingredients. Always consult your healthcare provider before starting treatment.",
"price": 243.0,
"discountamount": 73.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2462,
"imageuri": "https://productimages.withfloats.com/actual/6a43bee3de301bd6de277db2.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a43bee3de301bd6de277db2.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-06-30T13:04:34Z",
"updatedon": "2026-06-30T13:04:34Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//sitagliptin-100mg-metformin-hydrochloride-1000mg-sustained-release-pioglitazone-15-mg/2462",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ST GLIPTIN 3D 1000",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a153f150f3a1ec7df62ff41",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Glimepiride IP1 mg Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg",
"description": "Glimepiride Voglibose and Metformin Hydrochloride Tablets are a combination anti-diabetic medicine used for the effective management of Type 2 Diabetes Mellitus. This triple-action formulation helps control blood sugar levels through multiple mechanisms, making it highly beneficial for patients who are unable to achieve adequate glucose control with single-drug therapy.\n\nType 2 diabetes is a chronic metabolic disorder that affects the body’s ability to regulate blood sugar properly. Uncontrolled diabetes can lead to severe health complications such as heart disease, kidney damage, nerve disorders, vision problems, and poor circulation. This combination therapy is designed to provide comprehensive glycemic control by improving insulin action, reducing glucose production, and slowing carbohydrate absorption.\n\nDoctors commonly prescribe Glimepiride Voglibose and Metformin Hydrochloride Tablets to support long-term diabetes management and reduce the risk of diabetes-related complications.\n\nWhat are Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis medicine contains three active ingredients that work together to maintain healthy blood sugar levels:\n\nGlimepiride – A sulfonylurea anti-diabetic agent\nVoglibose – An alpha-glucosidase inhibitor\nMetformin Hydrochloride – A biguanide anti-diabetic medicine\n\nEach ingredient targets a different pathway involved in blood sugar regulation, offering a more effective approach for diabetes control.\n\nKey Benefits of Glimepiride Voglibose and Metformin Hydrochloride Tablets\n1. Helps Control Blood Sugar Levels Effectively\n\nThis combination medicine provides comprehensive glucose management throughout the day, especially after meals when blood sugar spikes are common.\n\n2. Improves Insulin Function\n\nGlimepiride stimulates the pancreas to release insulin, helping the body utilize glucose more efficiently.\n\n3. Reduces Excess Glucose Production\n\nMetformin decreases glucose production in the liver and improves insulin sensitivity, making it easier for the body to use available insulin.\n\n4. Controls Post-Meal Sugar Spikes\n\nVoglibose delays carbohydrate digestion and absorption in the intestine, helping prevent sudden increases in blood sugar after meals.\n\n5. Supports Long-Term Diabetes Management\n\nRegular use helps reduce the risk of complications associated with uncontrolled diabetes, such as kidney disease, nerve damage, and cardiovascular problems.\n\nHow Glimepiride Voglibose and Metformin Hydrochloride Tablets Work\n\nThis triple-drug combination works through complementary mechanisms:\n\nGlimepiride\n\nGlimepiride stimulates beta cells in the pancreas to release insulin. Increased insulin helps lower blood glucose levels by allowing sugar to enter body cells for energy use.\n\nVoglibose\n\nVoglibose inhibits enzymes responsible for breaking down complex carbohydrates into simple sugars. This slows glucose absorption from food and prevents rapid post-meal blood sugar rises.\n\nMetformin Hydrochloride\n\nMetformin reduces glucose production by the liver and enhances insulin sensitivity in muscles and tissues. It also helps decrease intestinal glucose absorption.\n\nTogether, these actions provide balanced and effective blood sugar control throughout the day.\n\nUses of Glimepiride Voglibose and Metformin Hydrochloride Tablets\n\nThis medicine is primarily prescribed for:\n\nType 2 Diabetes Mellitus\nPoorly controlled blood sugar levels\nPostprandial hyperglycemia (high blood sugar after meals)\nDiabetes management in overweight individuals\nCombination therapy when diet and exercise alone are insufficient\n\nIt is usually recommended along with proper diet, exercise, and lifestyle modifications.\n\nDosage and Administration\n\nThe dosage depends on blood sugar levels, patient response, and physician recommendations.\n\nGeneral Usage Guidelines\nUsually taken once or twice daily with meals\nSwallow tablets whole with water\nTake at the same time each day for consistent control\nFollow dietary advice strictly during treatment\n\nDo not skip meals while taking this medicine, as it may increase the risk of low blood sugar.\n\nPatients should regularly monitor blood glucose levels during therapy.\n\nPossible Side Effects\n\nLike any medication, Glimepiride Voglibose and Metformin Hydrochloride Tablets may cause side effects in some individuals.\n\nCommon Side Effects\nNausea\nDiarrhea\nAbdominal discomfort\nGas or bloating\nHeadache\nDizziness\nLow Blood Sugar Symptoms (Hypoglycemia)\n\nGlimepiride may occasionally cause low blood sugar, especially if meals are skipped.\n\nSymptoms include:\n\nSweating\nShaking\nHunger\nWeakness\nFast heartbeat\nConfusion\n\nKeeping a quick sugar source such as glucose tablets or juice is recommended.\n\nRare but Serious Side Effects\nSevere allergic reactions\nLactic acidosis (rare but serious with metformin)\nLiver-related issues\n\nImmediate medical attention should be sought if serious symptoms occur.\n\nPrecautions and Warnings\n\nBefore using this medicine, patients should inform their doctor about any existing medical conditions.\n\nImportant Precautions\nAvoid excessive alcohol consumption\nUse cautiously in kidney or liver disease\nRegular monitoring of kidney function may be required\nElderly patients may need dose adjustments\nInform the doctor before surgery or major illness\nPregnant or breastfeeding women should use only if prescribed\n\nMaintaining proper meal timing and lifestyle habits is important for safe and effective diabetes management.\n\nWho Should Use Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis medicine is suitable for:\n\nAdults with Type 2 Diabetes Mellitus\nPatients with uncontrolled post-meal glucose levels\nIndividuals requiring combination anti-diabetic therapy\nPatients not achieving adequate control with single medicines\nOverweight diabetic individuals needing insulin sensitivity improvement\n\nA healthcare professional will determine the appropriate treatment plan based on medical history and glucose profile.\n\nWhy Choose Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis combination therapy is preferred because it targets multiple aspects of diabetes simultaneously.\n\nAdvantages Include:\nTriple-action blood sugar control\nBetter post-meal glucose management\nImproved insulin utilization\nConvenient combination therapy\nReduces need for multiple separate medicines\nSupports long-term metabolic health\n\nIt offers comprehensive diabetes management in a single tablet formulation.\n\nLifestyle Tips for Better Diabetes Control\n\nAlong with medication, healthy lifestyle changes significantly improve diabetes management.\n\nRecommended Habits\nFollow a balanced diabetic diet\nExercise regularly\nMonitor blood sugar consistently\nMaintain healthy body weight\nAvoid smoking and excessive alcohol\nStay hydrated\nGet regular medical checkups\n\nThese habits help improve treatment effectiveness and reduce complications.\n\nStorage Instructions\nStore in a cool, dry place\nProtect from moisture and direct sunlight\nKeep out of reach of children\nUse only before expiry date\nBuyer Intent Summary\n\nIf you are searching for an effective combination medicine for Type 2 Diabetes management, Glimepiride Voglibose and Metformin Hydrochloride Tablets provide advanced blood sugar control through a triple-action mechanism. This medicine helps reduce fasting and post-meal sugar levels while improving insulin function and metabolic balance.",
"price": 262.0,
"discountamount": 79.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2428,
"imageuri": "https://productimages.withfloats.com/actual/6a153f17d73bfed7b4b4181f.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a153f17d73bfed7b4b4181f.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-05-26T06:35:01.356Z",
"updatedon": "2026-05-26T06:35:01.356Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg/2428",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIMITERIS MV1 0.2",
"category": "DIABETIC RANGE",
"tags": [
"glimepiride voglibose and metformin hydrochloride tablets",
"metformin glimepiride voglibose",
"glimepiride voglibose metformin",
"tab metformin glimepiride voglibose",
"glimepiride voglibose and metformin hydrochloride tablets uses",
"metformin hydrochloride glimepiride voglibose",
"metformin glimepiride voglibose 0.3",
"glimepiride voglibose and metformin sr tablets",
"glimepiride voglibose and metformin",
"metformin glimepiride voglibose uses",
"metformin glimepiride voglibose combination",
"metformin glimepiride voglibose 0.2",
"metformin glimepiride voglibose dose"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a06f0051c45b26e830ddf29",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "dapagliflozin 10 vildagliptin 100 metformin 1000",
"description": "Managing type 2 diabetes effectively requires the right combination of medicines, healthy eating habits, and an active lifestyle. Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets is a powerful triple-combination anti-diabetic medication designed to help control blood sugar levels in adults suffering from type 2 diabetes mellitus. This advanced formulation combines three clinically trusted medicines in one tablet to improve glycemic control and support long-term diabetic management.\n\nThis combination is commonly prescribed when blood sugar levels are not adequately controlled with a single medicine or dual therapy. It helps patients achieve better glucose regulation while reducing the risk of diabetes-related complications.\n\nWhat is Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets?\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets is a combination medication used for the treatment of Type 2 Diabetes Mellitus. It contains:\n\nDapagliflozin 10 mg\nVildagliptin SR 100 mg\nMetformin SR 1000 mg\n\nEach ingredient works through a different mechanism to provide comprehensive blood sugar control.\n\nThis medicine is generally recommended along with proper diet and exercise to improve overall diabetic management and reduce insulin resistance.\n\nComposition of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\n1. Dapagliflozin 10 mg\n\nDapagliflozin belongs to the SGLT2 inhibitor class of medicines. It works by removing excess glucose from the body through urine. This helps lower blood sugar levels naturally.\n\n2. Vildagliptin SR 100 mg\n\nVildagliptin is a DPP-4 inhibitor that increases incretin hormone levels in the body. These hormones help regulate insulin secretion and reduce glucose production by the liver.\n\n3. Metformin SR 1000 mg\n\nMetformin is one of the most trusted anti-diabetic medicines worldwide. It reduces glucose production in the liver and improves insulin sensitivity in the body.\n\nThe sustained-release (SR) formulation ensures gradual release of medicine for long-lasting action and better patient compliance.\n\nHow Do Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets Work?\n\nThis triple combination provides multidimensional control over blood sugar levels.\n\nDapagliflozin Works By:\nRemoving excess sugar through urine\nLowering fasting blood glucose\nSupporting weight management\nVildagliptin Works By:\nIncreasing insulin release after meals\nReducing glucagon secretion\nImproving pancreatic function\nMetformin Works By:\nReducing liver glucose production\nImproving insulin sensitivity\nLowering intestinal glucose absorption\n\nTogether, these medicines help maintain stable blood glucose levels throughout the day.\n\nBenefits of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\nEffective Blood Sugar Control\n\nThe combination targets multiple pathways involved in diabetes, helping achieve better glycemic control.\n\nReduced Risk of Diabetes Complications\n\nProper diabetes management lowers the risk of:\n\nKidney problems\nNerve damage\nHeart disease\nVision complications\nWeight Management Support\n\nDapagliflozin helps remove excess glucose, which may contribute to mild weight reduction in some patients.\n\nImproved Insulin Sensitivity\n\nMetformin enhances insulin utilization by body tissues.\n\nBetter Patient Compliance\n\nThree medicines in a single tablet reduce pill burden and simplify treatment.\n\nSustained Release Formula\n\nThe SR formulation provides extended therapeutic action and minimizes fluctuations in blood sugar levels.\n\nUses of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\n\nThis medicine is mainly prescribed for:\n\nType 2 Diabetes Mellitus\nUncontrolled diabetes despite dual therapy\nPatients requiring triple-drug glucose control\nImproving HbA1c levels\nManaging post-meal blood sugar spikes\n\nIt is generally not recommended for type 1 diabetes unless specifically advised by a healthcare professional.\n\nWho Can Take This Medicine?\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg tablets may be suitable for:\n\nAdults diagnosed with type 2 diabetes\nPatients with insulin resistance\nIndividuals requiring combination diabetic therapy\nPatients seeking convenient once-daily diabetic medication\n\nAlways use this medicine under medical supervision.\n\nDosage and Administration\nTake the tablet exactly as prescribed by your doctor.\nUsually taken once daily with meals.\nSwallow the tablet whole with water.\nDo not crush or chew sustained-release tablets.\nFollow dietary recommendations for best results.\n\nDosage may vary depending on blood sugar levels and patient response.\n\nPossible Side Effects\n\nLike all medicines, Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg tablets may cause some side effects.\n\nCommon Side Effects\nNausea\nDiarrhea\nFrequent urination\nHeadache\nStomach discomfort\nWeakness\nLess Common Side Effects\nUrinary tract infections\nGenital fungal infections\nDizziness\nLow blood sugar (especially with other anti-diabetic medicines)\nSerious Side Effects\n\nSeek immediate medical attention if you experience:\n\nSevere dehydration\nDifficulty breathing\nSevere abdominal pain\nSigns of allergic reaction\nPersistent vomiting\n\nMost side effects are mild and improve as the body adjusts to the medicine.\n\nPrecautions and Warnings\n\nBefore taking this medicine, inform your doctor if you have:\n\nKidney disease\nLiver disorders\nHeart disease\nHistory of pancreatitis\nDehydration issues\nAlcohol dependence\nImportant Precautions\nStay hydrated while taking dapagliflozin.\nMonitor blood sugar regularly.\nAvoid excessive alcohol consumption.\nFollow a diabetic-friendly diet.\n\nPregnant and breastfeeding women should consult a doctor before use.\n\nDrug Interactions\n\nThis medicine may interact with:\n\nInsulin\nSulfonylureas\nDiuretics\nBlood pressure medicines\nCorticosteroids\n\nAlways inform your doctor about all medications and supplements you are taking.\n\nStorage Instructions\nStore in a cool and dry place.\nKeep away from direct sunlight and moisture.\nStore below recommended room temperature.\nKeep out of reach of children.\n\nProper storage ensures medicine effectiveness and safety.\n\nWhy Choose Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets?\n\nThis advanced antidiabetic combination offers:\n\nTriple-action diabetes management\nLong-lasting blood sugar control\nConvenient dosing\nImproved patient adherence\nComprehensive glycemic regulation\n\nIt is widely preferred by healthcare professionals for patients requiring strong and reliable diabetic treatment.\n\nLifestyle Tips for Better Diabetes Management\n\nAlong with medication, patients should:\n\nMaintain a balanced diabetic diet\nExercise regularly\nMonitor blood glucose levels\nStay hydrated\nAvoid sugary foods\nFollow regular medical checkups\n\nHealthy lifestyle changes significantly improve treatment outcomes.\n\nFrequently Asked Questions\nIs Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets safe for long-term use?\n\nYes, when taken under medical supervision, it is generally considered safe for long-term diabetes management.\n\nCan this medicine help reduce HbA1c levels?\n\nYes, this combination is effective in lowering HbA1c and maintaining blood sugar control.\n\nDoes this medicine cause weight gain?\n\nDapagliflozin may support mild weight reduction in some patients.\n\nCan I stop the medicine once sugar levels improve?\n\nDo not stop taking the medicine without consulting your doctor.\n\nIs this medicine suitable for elderly patients?\n\nIt may be prescribed to elderly patients after proper medical evaluation.\n\nConclusion\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg tablets are a highly effective triple-combination therapy for managing type 2 diabetes mellitus. By combining the benefits of dapagliflozin, vildagliptin, and metformin SR, this medicine provides comprehensive blood sugar control, improves insulin sensitivity, and helps reduce diabetes-related complications.",
"price": 375.0,
"discountamount": 113.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2422,
"imageuri": "https://productimages.withfloats.com/actual/6a06f00b91493d06f6e7fcdf.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a06f00b91493d06f6e7fcdf.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-05-15T10:05:57.462Z",
"updatedon": "2026-06-05T07:31:14.082Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-vildagliptin-100-metformin-1000/2422",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "DAPAVILDA MET 10/100/1000",
"category": "DIABETIC RANGE",
"tags": [
"dapagliflozin 10 vildagliptin 100 metformin 1000",
"dapagliflozin vildagliptin metformin",
"dapagliflozin vildagliptin metformin combination",
"dapagliflozin vildagliptin metformin 1000",
"Dapagliflozin + Vildagliptin + Metformin Tablets",
"Buy Dapagliflozin + Vildagliptin + Metformin Tablets Online",
"Type 2 Diabetes Treatment Tablets",
"Blood Sugar Control Medicine with Dapagliflozin, Vildagliptin & Metformin",
"Triple Combination Anti-Diabetic Tablets",
"Best Diabetes Control Tablets for Type 2 Diabetes",
"Prescription Anti-Diabetic Medicine Tablets",
"Dapagliflozin 10 mg Vildagliptin 100 mg Metformin 1000 mg Product Image",
"Premium Quality Diabetic Care Tablets",
"Combination Diabetes Medicine for Glycemic Control",
"Type 2 Diabetes Management Tablets Online",
"Advanced Blood Sugar Control Tablets",
"Dapagliflozin Vildagliptin Metformin Tablets Supplier in India",
"Dapagliflozin Vildagliptin Metformin Tablets Manufacturer in India"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}